Reported Jan 13, 2021 · Terminated
labetalol HCl 20 mg/4 mL, Injection for Intravenous Use (5mg/mL), Rx Only, 4 mL Single Dose Syringe, SCA…
SCA Pharmaceuticals
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: SCA Pharmaceuticals · 755 Rainbow Rd Ste B · Windsor, CT · 06095-1024
Is this the product you have?
labetalol HCl 20 mg/4 mLInjection for Intravenous Use (5mg/mL)Rx Only4 mL Single Dose SyringeSCA Pharmaceuticals755 Rainbow RdWindsorCT06095barcode 70004070028
- Lot codes and dates
Lot # 1220022969BUD 3/1/20211220023002BUD 3/2/20211220023045BUD 3/2/20211220023081BUD 3/2/20211220023130BUD 3/6/20211220023229BUD 3/9/20211220023287BUD 3/12/2021 & 1220023335BUD 3/22/2021
- Amount recalled
- 9,057 syringes
This recall covers 32 products
The agency filed one notice per product. You are reading one of them; the other 31 are below.
19 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new SCA Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.